facebook page
Follow Me on Pinterest
twitter page
google plus page
rss feed

Recalled Product

Item detail and remedy information

Search Recalls or Browse by Category
Consumer Products (?)
Food & Health (?)
Vehicles (?)
Home > Recalled Products > Drugs > Package Tampering > Amneal Pharmaceuticals LLC Lorazepam Oral Concentrate, USP 2mg/mL

Recall: Amneal Pharmaceuticals LLC Lorazepam Oral Concentrate, USP 2mg/mL


On 2017-08-16, the FDA announced that Amneal Pharmaceuticals is conducting a recall on Lorazepam Oral Concentrate, USP 2mg/mL due to a possible package tampering. The recalled products were sold under the brand name(s) Amneal Pharmaceuticals LLC during an unspecified time period throughout the regions shown in the map below.

In recent months, there have been 2 drugs recalls due to potential package tampering, including mibelas 24 fe (norethindrone acetate and ethinyl estradiol 1 mg/0.02 mg chewable and ferrous fumarate 75 mg), weight loss product and more. Additionally, there have been 23 drug and medical device recalls due to other health hazards as well as 121 food recalls.

Email Me About Recalls On:
Food  |  Drugs  |  Medical Devices  |  Pet Care Products  |  All of These

Correctly printed dropper and the three misprinted droppers
Note: Images may not be available for every version. Please review the detailed description below.

Company Contact Information:

Name: Amneal Pharmaceuticals

Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.

Detailed Recall Information

Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.

Product Description: Lorazepam Oral Concentrate, USP 2mg/mL

Brand Name(s): Amneal Pharmaceuticals LLC

Reason for Recall: Misprinted Dosing Droppers

Official Recall Date: 2017-08-14

Note: Although this recall announcement is dated 08/14/2017, it was not published by the FDA until 08/16/2017.


Additional information provided by the

Amneal Pharmaceuticals LLC is voluntarily recalling 13 lots of Lorazepam Oral Concentrate, USP 2mg/mL, to the Consumer level due to a defect in the dropper markings. The Lorazepam Oral Concentrate, USP 2mg/mL, product is packaged with a dosing dropper, supplied to Amneal by a third party. In a few instances, the dropper is printed with the dose markings in reverse number order, has no dose markings or has dose markings that are shifted. Amneal learned about the issue from a Consumer's report. To date no adverse events related to these dropper defects have been reported to Amneal. The below picture shows examples of a dropper with the correct print, along with examples of droppers with the defects. Read More.

More information may be available at

Latest Safety Recalls

Select image for details, including additional styles.




Do you have comments or questions about this recall? Share them here.
Note: The recalling companies may not be monitoring these comments; they should be directed toward the public. Community Guidelines apply.
comments powered by Disqus
Back to Top

Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.

Search Recalled Products or Browse by Category
Consumer Products (?)
Food & Health (?)
Vehicles (?)
Latest Product Recalls
Register Products
Check for Recalls
Find Resources
Brands & Retailers
Connect to Customers

Consignment Sales
Check Inventory
Install Recall Finder
Take Safety Pledge

Home Inspectors
Check Appliances
APIs & Feeds
Recall Search for Web
Recall Search for Mobile
Facebook Apps

Product Recall Statistics